![]()
|
Report Date : |
01.10.2008 |
IDENTIFICATION
DETAILS
|
Name : |
VIVEK PHARMACHEM (INDIA) LIMITED |
|
|
|
|
Registered Office : |
NH – 8, Chimanpura, Amer, Jaipur – 302 004, Rajasthan |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
29.01.1990 |
|
|
|
|
Com. Reg. No.: |
005283 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24232RJ1990PLC005283 |
|
|
|
|
Legal Form : |
A Closely held Public Limited Company. |
|
|
|
|
Line of Business : |
Manufacturer of Pharmaceuticals Formulations. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 426000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well-established company having steady business. Trade
relations are fair. Payments are reported as slow but correct. However, the company can be considered normal for business dealings at
usual trade terms and conditions. |
LOCATIONS
|
Registered Office/ Factory : |
NH – 8, Chimanpura, Amer, Jaipur – 302 004, Rajasthan, India. |
|
Tel. No.: |
91-141-2530771-73 |
|
Mobile No.: |
91-9414060500 |
|
Fax No.: |
91-141-2530774/ 2603657 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
|
Name : |
Mr. Raj Kumar Gupta |
|
Designation : |
Director |
|
Address : |
C – 136, Dayanand Marg, Tilak Nagar, Jaipur, Rajasthan, India. |
|
Date of Birth/Age : |
09.11.1963 |
|
Date of Appointment : |
23.02.1995 |
|
Date of Ceasing : |
07.03.2005 |
|
|
|
|
Name : |
Mr. Kuldeep Gupta |
|
Designation : |
Managing Director |
|
Address : |
C – 136, Dayanand Marg, Tilak Nagar, Jaipur, Rajasthan, India. |
|
Date of Birth/Age : |
28.11.1936 |
|
Date of Appointment : |
29.01.1990 |
|
|
|
|
Name : |
Mr. Navdeep Gupta |
|
Designation : |
Whole Time Director |
|
Address : |
C – 136, Dayanand Marg, Tilak Nagar, Jaipur, Rajasthan, India. |
|
Date of Birth/Age : |
25.03.1966 |
|
Date of Appointment : |
29.01.1990 |
|
|
|
|
Name : |
Mrs. Savitri Gupta |
|
Designation : |
Director |
|
Address : |
C – 136, Dayanand Marg, Tilak Nagar, Jaipur, Rajasthan, India. |
|
Date of Appointment : |
07.03.2005 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 08.06.2005
|
Names of Shareholders |
No. of Shares |
|
Mr. Kuldeep Gupta |
478527 |
|
Mr. Kuldeep Gupta HUF |
91870 |
|
Mr. Navdeep Gupta |
542527 |
|
Mr. Navdeep Gupta HUF |
91870 |
|
Mr. Raj Kumar Gupta |
572703 |
|
Mrs. Savitri Gupta |
551493 |
|
Mrs. Aruna Gupta |
324867 |
|
Mrs. Neelam Gupta |
324666 |
|
Ms. Vrinda Gupta |
22300 |
|
Orchid Medicare Private Limited |
134000 |
|
Ms. Ayushi Gupta |
20510 |
|
Pacific Global Limited |
88500 |
|
Mr. Vinay Gupta |
280000 |
|
Total |
3523833 |
As on 29.09.2007
Equity share breakup (percentage of total equity)
|
Category |
Percentage |
|
Directors or relatives of directors |
100.000 |
|
Total |
100.000 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Formulations. |
|
|
|
GENERAL
INFORMATION
|
No. of Employees : |
About 120 |
|
|
|
|
Bankers : |
Bombay House, M.I. Road, Jaipur – 302 001, Rajasthan, India. |
|
|
|
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Jai Prakash Gupta Chartered Accountants |
|
Address : |
C-45, Greater Kailash Colony, Lal Kothi, Tonk Road, Jaipur – 302 015,
Rajasthan, India. |
|
|
|
|
Associates/Subsidiaries : |
NIL |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
5000000 |
Equity Shares |
Rs.10/- Each |
Rs.50.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
3523833 |
Equity Shares |
Rs.10/- Each |
Rs.35.238
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2007 |
31.03.2006 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
35.238 |
35.238 |
|
|
2] Share Application Money |
|
7.000 |
7.000 |
|
|
3] Reserves & Surplus |
|
42.888 |
27.862 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
85.126 |
70.100 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
104.541 |
87.174 |
|
|
2] Unsecured Loans |
|
40.073 |
35.790 |
|
|
TOTAL BORROWING |
|
144.614 |
122.964 |
|
|
DEFERRED TAX LIABILITIES |
|
12.694 |
16.718 |
|
|
|
|
|
|
|
|
TOTAL |
|
242.434 |
209.782 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
94.103 |
117.547 |
|
|
Capital work-in-progress |
|
83.813 |
17.113 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.001 |
0.001 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
20.707 |
20.906 |
|
|
Sundry Debtors |
|
85.173 |
96.910 |
|
|
Cash & Bank Balances |
|
4.188 |
0.908 |
|
|
Other Current Assets |
|
3.329 |
2.718 |
|
|
Loans & Advances |
|
9.010 |
33.696 |
|
Total
Current Assets |
|
122.407 |
155.138 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
|
56.556 |
78.160 |
|
|
Provisions |
|
1.334 |
1.857 |
|
Total
Current Liabilities |
|
57.890 |
80.017 |
|
|
Net Current Assets |
|
64.517 |
75.121 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
242.434 |
209.782 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
|
|
Sales Turnover |
|
258.064 |
208.654 |
|
|
Other Income |
|
1.306 |
12.710 |
|
|
Total Income |
|
259.370 |
221.364 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
11.258 |
12.426 |
|
|
Provision for Taxation |
|
5.287 |
-- |
|
|
Profit/(Loss) After Tax |
|
5.971 |
12.426 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Raw Material Consumed |
|
126.781 |
110.612 |
|
|
Increase/(Decrease) in Finished Goods |
|
(4.161) |
0.000 |
|
|
Salaries, Wages, Bonus, etc. |
|
7.119 |
1.005 |
|
|
Consumption of stores and spare parts |
|
41.420 |
0.000 |
|
|
Managerial Remuneration |
|
0.000 |
0.360 |
|
|
Payment to Auditors |
|
0.039 |
0.062 |
|
|
Insurance Expenses |
|
0.307 |
0.000 |
|
|
Power & Fuel |
|
3.933 |
0.000 |
|
|
Depreciation & Amortization |
|
23.611 |
15.219 |
|
|
Other Expenditure |
|
49.063 |
81.680 |
|
Total Expenditure |
|
248.112 |
208.938 |
|
KEY RATIOS
|
PARTICULARS |
|
|
31.03.2007 |
31.03.2006 |
|
PAT / Total Income |
(%) |
|
2.30 |
5.61 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
4.36 |
5.96 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
3.75 |
4.29 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
0.13 |
0.18 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
2.38 |
2.90 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
2.11 |
1.94 |
LOCAL AGENCY
FURTHER INFORMATION
|
Name of the company |
VIVEK PHARMACHEM (INDIA) LIMITED |
|
Presented By |
Mr. Raj Kumar Gupta, Director |
|
1) Date and description of instrument creating the change |
Dated 11.12.2004
|
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs.22.500
Millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
|
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Interest:
Interest on Term Loan @2.00% below BPLR i.e. 8.50% p.a. with monthly rests
subject to change by Bank/ RBI from time to time. Repayment: in 96
monthly installment of Rs.0.235 Million of which last is Rs.0.175 Million
with interest commencing from six month after date of disbursement. |
|
5) Name and Address and description of the person entitled to the charge. |
Bank of Baroda M.I. Road, Jaipur |
|
6) Date and brief description of instrument modifying the charge |
NA |
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
NA |
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified
|
80042862 |
|
Corporate
identity number of the company |
U24232RJ1990PLC005283 |
|
Name of the
company |
VIVEK PHARMACHEM (INDIA) LIMITED |
|
Address of the registered
office or of the principal place of
business in India of the company |
NH – 8, Chimanpura, Amer, Jaipur – 302 004, Rajasthan, India. |
|
Type of charge |
Immovable
Property Movable Property |
|
Particular of
charge holder |
Bank of Baroda Bombay House, M.I. Road, Jaipur – 302 001, Rajasthan, India. E-Mail: miroad@bankofbaroda.com |
|
Nature of
description of the instrument creating or modifying the charge |
|
|
Date of
instrument Creating the charge |
16.04.2008 |
|
Amount secured by
the charge |
Rs.174.200
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest:
Rate of interest has been revised as under;
Terms of
Repayment:
Margin:
Extent and Operation
of the charge: This charge will be treated as modification charge of original
charge created on 16.04.2008. |
|
Short particulars
of the property charged |
|
|
Date of latest
modification prior to the present modification |
18.03.2006 |
|
Particulars of
the present modification |
|
HISTORY:
They are establish pharmaceutical manufacturer from last twenty-five years. Their all products are well accepted throughout the country. They are working for Ranbaxy Laboratories Limited, Karnataka Antibiotic and Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Zydus-Cadila, Wockhart Limited, Intas Pharma Limited, Dr.Reddys Lab. Limited, Aristro Pharma Limited, and Pacific Global Limited.
To achieve global standards and international requirements they have
established a new manufacturing facility situated at NH-8, Chimanpura, Amer,
Jaipur on state-of-art technology and equipment to manufacture tablets,
capsules, dry and liquid Injectable, dry and oral liquid and powders in a self
contained dedicated unit as per the international regulatory requirements just
two year back. Their plant has been certified for WHO-GMP and ISO-9001:2000
certifications.
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is or
was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.94 |
|
UK Pound |
1 |
Rs.85.57 |
|
Euro |
1 |
Rs.67.79 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|